Correlation Between Salesforce and Novozymes A/S
Can any of the company-specific risk be diversified away by investing in both Salesforce and Novozymes A/S at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Novozymes A/S into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Novozymes AS B, you can compare the effects of market volatilities on Salesforce and Novozymes A/S and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Novozymes A/S. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Novozymes A/S.
Diversification Opportunities for Salesforce and Novozymes A/S
-0.85 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Salesforce and Novozymes is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Novozymes AS B in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novozymes AS B and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Novozymes A/S. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novozymes AS B has no effect on the direction of Salesforce i.e., Salesforce and Novozymes A/S go up and down completely randomly.
Pair Corralation between Salesforce and Novozymes A/S
Considering the 90-day investment horizon Salesforce is expected to generate 1.04 times more return on investment than Novozymes A/S. However, Salesforce is 1.04 times more volatile than Novozymes AS B. It trades about 0.23 of its potential returns per unit of risk. Novozymes AS B is currently generating about -0.1 per unit of risk. If you would invest 29,640 in Salesforce on August 31, 2024 and sell it today you would earn a total of 3,361 from holding Salesforce or generate 11.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Salesforce vs. Novozymes AS B
Performance |
| Timeline |
| Salesforce |
| Novozymes AS B |
Salesforce and Novozymes A/S Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and Novozymes A/S
The main advantage of trading using opposite Salesforce and Novozymes A/S positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Novozymes A/S can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novozymes A/S will offset losses from the drop in Novozymes A/S's long position.| Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify | Salesforce vs. Workday |
| Novozymes A/S vs. Sherwin Williams Co | Novozymes A/S vs. Air Liquide SA | Novozymes A/S vs. LAir Liquide SA | Novozymes A/S vs. Air Products and |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stocks Directory Find actively traded stocks across global markets |